Portfolio (Quarterly)
Guide ↗
Forefront Analytics, LLC
· CIK 0001696802| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | EES | WISDOMTREE TR | — | 7,020.0 | $476K | 0.52% | NEW | — | $67.79 | +0.4% |
| 22 | PFE | PFIZER INC | Healthcare | 18,210.0 | $438K | 0.48% | NEW | — | $24.08 | +17.9% |
| 23 | MDT | MEDTRONIC PLC | Healthcare | 5,319.0 | $416K | 0.45% | NEW | — | $78.23 | +17.5% |
| 24 | DHR | DANAHER CORP DEL | Healthcare | 2,040.0 | $389K | 0.42% | NEW | — | $190.44 | +13.0% |
| 25 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 669.0 | $336K | 0.36% | NEW | — | $501.67 | +25.0% |
| 26 | — | BLUE OWL TECHNOLOGY FIN CORP | — | 29,654.0 | $307K | 0.33% | NEW | — | $10.35 | — |
| 27 | LEGN | LEGEND BIOTECH CORP | Healthcare | 10,568.0 | $305K | 0.33% | NEW | — | $28.88 | -26.0% |
| 28 | PM | PHILIP MORRIS INTL INC | Consumer Defensive | 1,463.0 | $265K | 0.29% | NEW | — | $180.86 | +6.6% |
| 29 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 415.0 | $259K | 0.28% | NEW | — | $623.69 | +33.8% |
| 30 | SCHD | SCHWAB STRATEGIC TR | — | 7,676.0 | $243K | 0.27% | NEW | — | $31.71 | +10.6% |
| 31 | VTV | VANGUARD INDEX FDS | — | 1,084.0 | $236K | 0.26% | NEW | — | $218.01 | +3.9% |
| 32 | — | ZURA BIO LTD | — | 26,968.0 | $159K | 0.17% | NEW | — | $5.90 | — |
| 33 | GERN | GERON CORP | Healthcare | 88,779.0 | $114K | 0.12% | NEW | — | $1.28 | +20.3% |
| 34 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 25,033.0 | $94K | 0.10% | NEW | — | $3.75 | -10.0% |
| 35 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | 21,822.0 | $93K | 0.10% | NEW | — | $4.24 | +3.6% |
| 36 | NKTX | NKARTA INC | Healthcare | 28,955.0 | $82K | 0.09% | NEW | — | $2.83 | -4.4% |
| 37 | ANNX | ANNEXON INC | Healthcare | 14,240.0 | $81K | 0.09% | NEW | — | $5.71 | -9.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
42.5%
Technology
34.3%
Financial Services
14.4%
Industrials
6.5%
Consumer Defensive
2.3%